[ Price : $8.95]
Consulting editor John Scharmann reviews the growing number of attorneys being hired by diverse FDA offices for purposes already s...[ Price : $8.95]
FDAs Anti-infective Drugs Advisory Committee votes 15-2 to recommend that Gileads aztreonam is safe and effective in treating lung...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance, Patient-Reported Outcome Measures Use in Medical Product Development to Support ...[ Price : $8.95]
An FDA final rule will require producers of PET drugs to submit NDAs or ANDAs for their drugs starting in two years.[ Price : $8.95]
The Obama administration sends mixed signals on whether it supports legislation to permit drug importation.[ Price : $8.95]
Repligen reports mixed results from a Phase 3 clinical trial evaluating RG1068, a synthetic human secretin intended to improve mag...[ Price : $8.95]
Protalix Biotherapeutics submits an NDA for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) for treati...[ Price : $8.95]
Federal Register Notice: FDA establishes a public docket to obtain suggestions on elements for an approved tobacco retailer traini...